<?xml version="1.0" encoding="utf-8"?>
<items><story><date>12:02 03 January 2007 (UTC)</date><text>LONDON Jan 3 Global pharmaceutical sales grew 5
percent in the 12 months to October in leading markets,
healthcare information company IMS Health said on Wednesday. Sales through retail pharmacies in 13 leading markets, which
account for around two-thirds of the world market, totalled
$383.7 billion in the period. Sales in the top five European markets grew 4 percent at
constant exchange rates, while North American sales increased 7
percent. The largest drug class worldwide in the year to October
remained cholesterol-lowering medicines, which sold $30.3
billion and showed a growth rate of 8 percent. Pfizer Inc's (PFE.N) Lipitor cholesterol pill remained the
top-selling drug in leading markets, with sales of $11.7
billion, followed by AstraZeneca Plc's (AZN.L) Nexium,
GlaxoSmithKline Plc's (GSK.L) Advair/Seretide and Sanofi-Aventis
SA (SASY.PA) and Bristol-Myers Squibb Co's (BMY.N) Plavix.



</text><link>http://www.reuters.com/article/2007/01/03/pharmaceuticals-sales-idUSB21359720070103</link><sectors></sectors><title>drug sales in top markets up 5 % in year to october</title></story></items>